Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration

Radiotherapy and Oncology

Volumn 66, Issue 2, 2003, Pages 217-224

  Parker, C C ^a   Damyanovich, A ^a   Haycocks, T ^a   Haider, M ^a   Bayley, A ^a   Catton, C N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Computed tomography; Fiducial markers; Magnetic resonance imaging; Prostate cancer; Prostate contouring

Indexed keywords

GOLD ALLOY;

ARTICLE; BONE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; ONLINE SYSTEM; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT PLANNING;

EID: 0037295469     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00407-3     Document Type: Article

References (22)

1. Alasti H., Petric P., Catton C., Warde P. Portal imaging for daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 49:2001;869-884.
2. Antolak J., Rosen I., Childress C., et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 42:1998;661-672.
3. Chen M., Johnston D., Tang K., et al. Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer. 89:(8):2000;1800-1809.
4. Dearnaley D., Khoo V., Norman A., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 353:1999;267-272.
5. Debois M., Oyen R., Maes F., et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys. 45:(4):1999;857-865.
6. Dubois D., Prestidge B., Hotchkiss L., et al. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 207:(3):1998;785-789.
7. Fiorino C., Reni M., Bolognes I., et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol. 47:(3):1998;285-292.
8. Jackson A., Skwarchuk M., Zelefsky M., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 49:(3):2001;685-698.
9. Kagawa K., Lee W.R., Schultheiss T.E., Hunt M.A., Shaer A.H., Hanks G.E. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys. 38:(2):1997;319-325.
10. Khoo V., Dearnaley D., Finnigan D., et al. Magnetic resonance imaging (MRI): Considerations and applications in radiotherapy treatment planning. Radiother Oncol. 42:(1):1997;1-15.
11. Litzenberg D., Dawson L., Sandler H., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys. 52:2002;699-703.
12. Malone S., Crook J., Kendal W., Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys. 48:(1):2000;105-109.
13. Padhani A., Khoo V., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys. 44:(3):1999;525-533.
14. Pickett B., Vigneault E., Kurhanewicz J., et al. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 44:(4):1999;921-929.
15. Pollack A., Zagars G., Smith L., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911.
16. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 43:(1):1999;57-66.
17. Roach M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 35:(5):1996;1011-1018.
18. Roeske J., Forman J., Mesina C., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 33:(5):1995;1321-1329.
19. Sannazzari G., Ragona R., Ruo Redda M., et al. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol. 75:(895):2002;603-607.
20. Tanner S., Finnigan D., Khoo V., et al. Radiotherapy planning of the pelvis using distortion corrected MR images: the removal of system distortions. Phys Med Biol. 45:(8):2000;2117-2132.
21. Vigneault E., Pouliot J., Laverdiere J., et al. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate motion during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys. 37:1997;205-212.
22. Wu J., Haycocks T., Alasti H., et al. Portal film analysis of an escalated dose conformal prostatic irradiation protocol using fiducial markers and portal images to confirm target organ and isocenter position. Radiother Oncol. 61:(2):2001;127-135.